First Time Loading...

Integra Lifesciences Holdings Corp
NASDAQ:IART

Watchlist Manager
Integra Lifesciences Holdings Corp Logo
Integra Lifesciences Holdings Corp
NASDAQ:IART
Watchlist
Price: 28.75 USD -1.47% Market Closed
Updated: May 3, 2024

Integra Lifesciences Holdings Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Integra Lifesciences Holdings Corp
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Integra Lifesciences Holdings Corp
NASDAQ:IART
Operating Income
$271.8m
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
22%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.1B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.5B
CAGR 3-Years
46%
CAGR 5-Years
7%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Operating Income
$4.5B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.6B
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$1.9B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
11%

See Also

What is Integra Lifesciences Holdings Corp's Operating Income?
Operating Income
271.8m USD

Based on the financial report for Dec 31, 2023, Integra Lifesciences Holdings Corp's Operating Income amounts to 271.8m USD.

What is Integra Lifesciences Holdings Corp's Operating Income growth rate?
Operating Income CAGR 10Y
22%

Over the last year, the Operating Income growth was -7%. The average annual Operating Income growth rates for Integra Lifesciences Holdings Corp have been 7% over the past three years , 3% over the past five years , and 22% over the past ten years .